首页> 外文会议>Biophotonics: photonic solutions for better health care IV >Measurement and quantification of fluorescent changes in ocular tissue using a novel confocal instrument
【24h】

Measurement and quantification of fluorescent changes in ocular tissue using a novel confocal instrument

机译:使用新型共聚焦仪器测量和定量眼组织中的荧光变化

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Our sight is a major contributor to our quality of life. The treatment of diseases like macular degeneration and glaucoma, however, presents a challenge as the delivery of medication to ocular tissue is not well understood. The instrument described here will help quantify targeted delivery by non-invasively and simultaneously measuring light reflected from and fluorescence excited in the eye, used as position marker and to track compounds respectively.The measurement concept has been proven by monitoring the diffusion of fluorescein and a pharmaceutical compound for treating open angle glaucoma in vitro in a cuvette and in ex vivo porcine eyes. To obtain a baseline of natural fluorescence we measured the change in corneal and crystalline lens autofluorescence in volunteers over a week. We furthermore present data on 3D ocular autofluorescence. Our results demonstrate the capability to measure the location and concentration of the compound of interest with high axial and temporal resolution of 178 μm and 0.6 s respectively. The current detection limit is 2 μM for fluorescein, and compounds with a quantum yield as low as 0.01 were measured to concentrations below 1 μM. The instrument has many applications in assessing the diffusion of fluorescent compounds through the eye and skin in vitro and in vivo, measuring autofluorescence of ocular tissues and reducing the number of animals needed for research. The instrument has the capability of being used both in the clinical and home care environment opening up the possibility of measuring controlled drug release in a patient friendly manner.
机译:我们的视力是我们生活质量的主要贡献者。然而,由于对药物向眼组织的递送了解不多,因此诸如黄斑变性和青光眼的疾病的治疗提出了挑战。此处描述的仪器将通过无创地同时测量从眼睛反射的光和在眼睛中激发的荧光来帮助量化目标递送,分别用作位置标记和跟踪化合物。该测量概念已通过监测荧光素和用于在试管和离体猪眼中体外治疗开角型青光眼的药物化合物。为了获得自然荧光的基线,我们测量了志愿者一周内角膜和晶状体自身荧光的变化。我们还提出了有关3D眼自发荧光的数据。我们的结果证明了分别以178μm和0.6 s的高轴向和时间分辨率测量目标化合物的位置和浓度的能力。荧光素的当前检测极限为2μM,并且测得量子产率低至0.01的化合物的浓度低于1μM。该仪器在评估荧光化合物在体外和体内通过眼睛和皮肤的扩散,测量眼组织的自发荧光以及减少研究所需的动物数量方面有许多应用。该仪器具有在临床和家庭护理环境中使用的能力,从而开创了以患者友好的方式测量药物受控释放的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号